Clinical acceptability of fully automated external beam radiotherapy for cervical cancer with three different beam delivery techniques.


Journal

Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746

Informations de publication

Date de publication:
Sep 2022
Historique:
revised: 16 06 2022
received: 05 11 2021
accepted: 12 07 2022
pubmed: 23 7 2022
medline: 15 9 2022
entrez: 22 7 2022
Statut: ppublish

Résumé

To fully automate CT-based cervical cancer radiotherapy by automating contouring and planning for three different treatment techniques. We automated three different radiotherapy planning techniques for locally advanced cervical cancer: 2D 4-field-box (4-field-box), 3D conformal radiotherapy (3D-CRT), and volumetric modulated arc therapy (VMAT). These auto-planning algorithms were combined with a previously developed auto-contouring system. To improve the quality of the 4-field-box and 3D-CRT plans, we used an in-house, field-in-field (FIF) automation program. Thirty-five plans were generated for each technique on CT scans from multiple institutions and evaluated by five experienced radiation oncologists from three different countries. Every plan was reviewed by two of the five radiation oncologists and scored using a 5-point Likert scale. Overall, 87%, 99%, and 94% of the automatically generated plans were found to be clinically acceptable without modification for the 4-field-box, 3D-CRT, and VMAT plans, respectively. Some customizations of the FIF configuration were necessary on the basis of radiation oncologist preference. Additionally, in some cases, it was necessary to renormalize the plan after it was generated to satisfy radiation oncologist preference. Approximately, 90% of the automatically generated plans were clinically acceptable for all three planning techniques. This fully automated planning system has been implemented into the radiation planning assistant for further testing in resource-constrained radiotherapy departments in low- and middle-income countries.

Identifiants

pubmed: 35866442
doi: 10.1002/mp.15868
pmc: PMC9474595
mid: NIHMS1825032
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5742-5751

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : UH2 CA202665
Pays : United States
Organisme : NCI NIH HHS
ID : UH3 CA202665
Pays : United States
Organisme : National Institutes of Health/National Cancer Institute
ID : UH3-CA202665
Organisme : National Institutes of Health/National Cancer Institute
ID : P30-CA016672
Organisme : National Institutes of Health/National Cancer Institute
ID : UH2-CA202665

Informations de copyright

© 2022 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.

Références

J Appl Clin Med Phys. 2017 Jan;18(1):25-31
pubmed: 28291936
Med Phys. 2020 Nov;47(11):5592-5608
pubmed: 33459402
Radiother Oncol. 2006 Jan;78(1):67-77
pubmed: 16403584
J Vis Exp. 2018 Apr 11;(134):
pubmed: 29708544
J Appl Clin Med Phys. 2022 Jun;23(6):e13614
pubmed: 35488508
Med Dosim. 2016 Spring;41(1):9-14
pubmed: 26212351
Pract Radiat Oncol. 2022 Jul-Aug;12(4):e344-e353
pubmed: 35305941
Med Phys. 2022 Sep;49(9):5742-5751
pubmed: 35866442
J Appl Clin Med Phys. 2022 Sep;23(9):e13712
pubmed: 35808871
Clin Transl Radiat Oncol. 2018 Jan 11;9:48-60
pubmed: 29594251
Med Phys. 2020 Nov;47(11):5648-5658
pubmed: 32964477
J Glob Oncol. 2019 Jan;5:1-9
pubmed: 30629457
Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):164-172
pubmed: 27979445
PLoS One. 2016 Dec 29;11(12):e0169202
pubmed: 28033342
Pract Radiat Oncol. 2020 Sep - Oct;10(5):e415-e424
pubmed: 32450365
J Appl Clin Med Phys. 2022 Aug;23(8):e13647
pubmed: 35580067
Med Dosim. 2020 Summer;45(2):172-178
pubmed: 31740042

Auteurs

Dong Joo Rhee (DJ)

Medical Physics, The University of Texas Graduate School of Biomedical Sciences, at Houston, Houston, Texas, USA.
Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Anuja Jhingran (A)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Kai Huang (K)

Medical Physics, The University of Texas Graduate School of Biomedical Sciences, at Houston, Houston, Texas, USA.
Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Tucker J Netherton (TJ)

Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Nazia Fakie (N)

Division of Radiation Oncology and Medical Physics, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.

Ingrid White (I)

Radiotherapy Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Alicia Sherriff (A)

Department of Oncology, University of the Free State, Bloemfontein, South Africa.

Carlos E Cardenas (CE)

Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

Lifei Zhang (L)

Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Surendra Prajapati (S)

Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Stephen F Kry (SF)

Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Beth M Beadle (BM)

Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA.

William Shaw (W)

Department of Medical Physics (G68), University of the Free State, Bloemfontein, South Africa.

Frederika O'Reilly (F)

Department of Medical Physics (G68), University of the Free State, Bloemfontein, South Africa.

Jeannette Parkes (J)

Division of Radiation Oncology and Medical Physics, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.

Hester Burger (H)

Division of Radiation Oncology and Medical Physics, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.

Chris Trauernicht (C)

Division of Medical Physics, Tygerberg Academic Hospital, Stellenbosch University, Cape Town, South Africa.

Hannah Simonds (H)

Division of Radiation Oncology, Tygerberg Academic Hospital, Stellenbosch University, Cape Town, South Africa.

Laurence E Court (LE)

Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH